Exelixis Inc (EXEL)
21.38
-0.38
(-1.75%)
USD |
NASDAQ |
May 10, 16:00
21.38
0.00 (0.00%)
After-Hours: 19:31
Exelixis Accounts Payable (Quarterly): 26.07M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 26.07M |
December 31, 2023 | 33.77M |
September 30, 2023 | 26.45M |
June 30, 2023 | 25.99M |
March 31, 2023 | 32.62M |
December 31, 2022 | 32.67M |
September 30, 2022 | 30.57M |
June 30, 2022 | 19.98M |
March 31, 2022 | 17.28M |
December 31, 2021 | 24.26M |
September 30, 2021 | 24.31M |
June 30, 2021 | 20.45M |
March 31, 2021 | 13.82M |
December 31, 2020 | 23.63M |
September 30, 2020 | 47.93M |
June 30, 2020 | 9.103M |
March 31, 2020 | 15.32M |
December 31, 2019 | 11.58M |
September 30, 2019 | 8.352M |
June 30, 2019 | 12.27M |
March 31, 2019 | 9.748M |
December 31, 2018 | 10.90M |
September 30, 2018 | 8.679M |
June 30, 2018 | 13.02M |
March 31, 2018 | 11.08M |
Date | Value |
---|---|
December 31, 2017 | 9.575M |
September 30, 2017 | 5.988M |
June 30, 2017 | 7.037M |
March 31, 2017 | 4.649M |
December 31, 2016 | 6.565M |
September 30, 2016 | 3.965M |
June 30, 2016 | 5.435M |
March 31, 2016 | 5.657M |
December 31, 2015 | 6.401M |
September 30, 2015 | 2.256M |
June 30, 2015 | 3.398M |
March 31, 2015 | 1.303M |
December 31, 2014 | 6.413M |
September 30, 2014 | 3.362M |
June 30, 2014 | 4.638M |
March 31, 2014 | 4.943M |
December 31, 2013 | 9.345M |
September 30, 2013 | 3.559M |
June 30, 2013 | 3.458M |
March 31, 2013 | 3.498M |
December 31, 2012 | 4.398M |
September 30, 2012 | 3.246M |
June 30, 2012 | 2.931M |
March 31, 2012 | 1.878M |
December 31, 2011 | 1.957M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
8.352M
Minimum
Sep 2019
47.93M
Maximum
Sep 2020
22.82M
Average
23.94M
Median
Accounts Payable (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 671.30M |
Johnson & Johnson | 8.174B |
Merck & Co Inc | 3.514B |
Pfizer Inc | 5.591B |
Legend Biotech Corp | 19.56M |